Enviroment / FDA and Healthcare / Finance and Restructuring / Intellectual Property - Morgan Lewis & Bockius LLP
Morgan Lewis's Environmental Practice is anchored by a team of high-level government agency alumni and veteran environmental attorneys who deliver customized counseling on permitting, compliance, risk avoidance, crisis management, and litigation matters. For clients ranging from startups to established global corporations, we provide guidance in environmental enforcement actions, in civil or criminal matters involving current operations or legacy environmental issues, in transactions, on securing permits and government approvals, and on strategies and challenges related to climate change. One of the first environmental practices established at a major law firm, we combine powerful historical perspective on evolving public and legislative policy with experience across a wide range of industries, including, among others, manufacturing, chemicals, energy, transportation, real estate, and retail.
Problem prevention to protect the client’s bottom line is a major focus of the Environmental Practice. We perform internal audits, conduct training programs, and provide individually tailored reference materials designed to ensure our clients’ compliance with the laws and regulations applicable to their particular operations. When disputes arise or litigation is unavoidable, Morgan Lewis leverages its demonstrated trial skill as a powerful negotiating tool in defending private or public agency lawsuits, in handling cost recovery actions under Superfund or related statutes, and in compelling insurance coverage of a client’s environmental liabilities. In the event of emergencies such as spills, explosions, fires, or accidents, we have on standby a coordinated Environmental/OSHA crisis team that can deploy at any hour to facilitate a proper response and minimize liability issues.
FDA and Healthcare
Morgan Lewis’s FDA and Healthcare Practice provides comprehensive counsel to an array of healthcare industry clients, including those within the pharmaceutical, biotech, medical device, diagnostics, food and drug, and healthcare provider sectors. We provide thorough legal and scientific advice to companies concerning products regulated by the U.S. Food and Drug Administration, the Centers for Medicare and Medicaid Services and related regulatory agencies in the United States, European Union and Asia. While we also help clients navigate healthcare legislation and reform, our structure and counsel is expressly designed to protect the complete lifecycle of a product—from conception, testing and development to national and international commercialization.
One of the largest combined FDA and healthcare practices in the nation, we leverage our core healthcare attorneys, a diverse team of professionals with advanced scientific degrees, and a pool of 200 other life sciences-focused attorneys to support the full scope of healthcare litigation, regulatory and transactional needs of our clients. The firm's resources across 22 domestic and international offices lend us the global capacity to advance our clients’ objectives with precision and efficiency.
Bankruptcy and Restructuring
Morgan Lewis’s Bankruptcy and Restructuring Practice represents leading financial institutions and public and private companies in the full spectrum of finance and restructuring matters—from traditional bank financings to complex securitizations, workouts, and bankruptcies, including multinational and cross-border transactions. We help tailor transactions to our clients’ individual objectives, providing creative solutions customized to current market conditions and to the particular considerations of the businesses or industries involved. Our practice is full-service; we handle all aspects of due diligence, contract negotiations, “stalking horse” procedures, auctions, and closings. We also frequently represent our clients in litigation relating to preferences, fraudulent conveyances, and other avoidance actions.
Backed by the firm’s global resources and experience serving most major industries, lawyers in the Bankruptcy and Restructuring Practice bring to their representations an intimate familiarity with a broad range of businesses and their specific concerns: entertainment, retail, sports, telecommunications, acquisition financing, shipping, energy, real estate and REITs, broker/dealers, manufacturers, mortgage trusts, and royalty streams. We offer years of experience in complex financings and reorganizations and are recognized leaders in entertainment industry transactions, DIP financings, and exit lending.
The Intellectual Property Practice consists of more than 150 lawyers and professionals, many with advanced degrees in engineering and the sciences. The group provides full service on all intellectual property matters. We prosecute patents, register trademarks and copyrights, provide counseling and opinions, handle transactions and due diligence, and litigate intellectual property cases. In these representations, we leverage a collective command of a broad industries and technologies, such as computer hardware and software; electronics; pharmaceuticals, biotechnology, and medical devices; food and beverage; consumer products; and financial services. The Intellectual Property team includes former members of the Board of Patent Appeals and Interferences and former patent examiners with the U.S. Patent and Trademark Office.
Our clients span the globe and range from worldwide leaders to small startups. We have litigated intellectual property cases in more than 35 states as well as before the International Trade Commission, the U.S. Patent and Trademark Office, and in arbitrations. We have a record of success before judges and juries with both plaintiff and defense verdicts in some of the largest IP cases in the country. Our lawyers regularly appear before the U.S. Court of Appeals for the Federal Circuit and the Trademark Trial and Appeal Board.